PharmaCyte Biotech, Inc. PMCB
PMCB
PharmaCyte Biotech, Inc. RADX
Radiopharm Theranostics Limited QNRX
Quoin Pharmaceuticals, Ltd. NBY
NovaBay Pharmaceuticals, Inc. TCRT
Alaunos Therapeutics, Inc. VIVS
VivoSim Labs, Inc. IBO
Impact BioMedical Inc. KTTA
Pasithea Therapeutics Corp. PLRZ
Polyrizon Ltd. CYCN
Cyclerion Therapeutics, Inc.
PharmaCyte Biotech, Inc. RADX
Radiopharm Theranostics Limited QNRX
Quoin Pharmaceuticals, Ltd. NBY
NovaBay Pharmaceuticals, Inc. TCRT
Alaunos Therapeutics, Inc. VIVS
VivoSim Labs, Inc. IBO
Impact BioMedical Inc. KTTA
Pasithea Therapeutics Corp. PLRZ
Polyrizon Ltd. CYCN
Cyclerion Therapeutics, Inc.
Performance
| Periode | PMCB | RADX | QNRX | NBY | TCRT | VIVS | IBO | KTTA | PLRZ | CYCN |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -19.09 % | 15.08 % | 63.22 % | 829.82 % | -17.02 % | 35.62 % | 79.26 % | 55.08 % | 115.79 % | -50.85 % |
| YTD | -47.71 % | 11.85 % | -39.63 % | 741.27 % | 80.71 % | 15.12 % | -57.85 % | -60.41 % | -99.66 % | -55.93 % |
| 1Y | -47.71 % | 16.37 % | -37.31 % | 960.00 % | 76.24 % | 15.12 % | -61.13 % | -56.55 % | -99.73 % | -50.85 % |
| 3Y | -70.33 % | -70.63 % | -97.68 % | -89.48 % | -95.64 % | 15.12 % | -75.78 % | -92.27 % | -99.59 % | -88.11 % |
| 5Y | -88.93 % | -70.63 % | -99.97 % | -99.31 % | -99.15 % | 15.12 % | -75.78 % | -98.37 % | -99.59 % | -97.78 % |
| 10Y | -99.16 % | -70.63 % | -100.00 % | -99.88 % | -99.71 % | 15.12 % | -75.78 % | -98.37 % | -99.59 % | -99.42 % |
| Depuis le début | -98.50 % | -70.63 % | -100.00 % | -100.00 % | -99.85 % | 15.12 % | -75.78 % | -98.37 % | -99.59 % | -99.42 % |